EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors

Autor: Cliona M. Rooney, Patrick C. Rämer, Christian Münz, Jaap M. Middeldorp, Fathima Zumla Cader, John G. Gribben, Martin J. Allday, Barbara Savoldo, Rita Coutinho, Paul Murray, Jamie P. Nourse, Sonja Meixlsperger, Laurie Pinaud, Hazem A. H. Ibrahim, Robert E. White, Csaba Bödör, Maher K. Gandhi, Mark Bower, Kikkeri N. Naresh
Přispěvatelé: University of Zurich, Münz, Christian, Pathology, CCA - Oncogenesis
Jazyk: angličtina
Rok vydání: 2012
Předmět:
Epstein-Barr Virus Infections
Herpesvirus 4
Human

Genes
Viral

DNA Mutational Analysis
Mice
SCID

2700 General Medicine
10263 Institute of Experimental Immunology
medicine.disease_cause
Mice
Postoperative Complications
Mice
Inbred NOD

hemic and lymphatic diseases
Genes
Tumor Suppressor

Cell Line
Transformed

Mice
Knockout

education.field_of_study
Hematopoietic Stem Cell Transplantation
General Medicine
medicine.anatomical_structure
Research Article
Lymphoma
B-Cell

T cell
Transplantation
Heterologous

Population
610 Medicine & health
Biology
Interferon-gamma
Immune system
Antigen
medicine
Animals
Humans
education
B cell
Chimera
Tumor Suppressor Proteins
Cell Transformation
Viral

medicine.disease
Virology
Epstein–Barr virus
Lymphoproliferative Disorders
Lymphoma
Chemokine CXCL10
Tumor Virus Infections
Epstein-Barr Virus Nuclear Antigens
Mutation
Cancer research
570 Life sciences
biology
Diffuse large B-cell lymphoma
Gene Deletion
Zdroj: Journal of Clinical Investigation, 122(4), 1487-1502. The American Society for Clinical Investigation
White, R E, Raemer, P C, Naresh, K N, Meixlsperger, S, Pinaud, L, Rooney, C, Savoldo, B, Coutinho, R, Bodor, C, Gribben, J, Ibrahim, H A, Bower, M, Nourse, J P, Gandhi, M K, Middeldorp, J M, Cader, F Z, Murray, P, Munz, C & Allday, M J 2012, ' EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors ', Journal of Clinical Investigation, vol. 122, no. 4, pp. 1487-1502 . https://doi.org/10.1172/JCI58092
ISSN: 0021-9738
DOI: 10.1172/JCI58092
Popis: Epstein-Barr virus (EBV) persistently infects more than 90% of the human population and is etiologically linked to several B cell malignancies, including Burkitt lymphoma (BL), Hodgkin lymphoma (HL), and diffuse large B cell lymphoma (DLBCL). Despite its growth transforming properties, most immune-competent individuals control EBV infection throughout their lives. EBV encodes various oncogenes, and of the 6 latency-associated EBV-encoded nuclear antigens, only EBNA3B is completely dispensable for B cell transformation in vitro. Here, we report that infection with EBV lacking EBNA3B leads to aggressive, immune-evading monomorphic DLBCL-like tumors in NOD/SCID/γc–/– mice with reconstituted human immune system components. Infection with EBNA3B-knockout EBV (EBNA3BKO) induced expansion of EBV-specific T cells that failed to infiltrate the tumors. EBNA3BKO-infected B cells expanded more rapidly and secreted less T cell–chemoattractant CXCL10, reducing T cell recruitment in vitro and T cell–mediated killing in vivo. B cell lines from 2 EBV-positive human lymphomas encoding truncated EBNA3B exhibited gene expression profiles and phenotypic characteristics similar to those of tumor-derived lines from the humanized mice, including reduced CXCL10 secretion. Screening EBV-positive DLBCL, HL, and BL human samples identified additional EBNA3B mutations. Thus, EBNA3B is a virus-encoded tumor suppressor whose inactivation promotes immune evasion and virus-driven lymphomagenesis.
Databáze: OpenAIRE